Cliquez pour voir la ligne de temps
Ligne de temps
Anciennes Équipes
Publications
Télécharger-
2025Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control., Sci Adv 2025 Aug; 11(33): eadv0871.
-
2015RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells, Science. 2015 Sep 24. pii: aad0395. [Epub ahead of print].
-
2013Tracking antigen-specific CD8⁺ T cells using MHC class I multimers., Methods Mol. Biol. 2013 ; 960(): 309-326.
-
2012Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer, Sci Transl Med 2012 Jun;4(137):137ra72.
-
2011Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery, Front Immunol 2011;2:71.
-
2009Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells, Cell Death Differ. 2009 Jul;16(7):991-1005.
-
2008Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming, J. Immunol. 2008 Sep;181(5):3067-76.
-
2006IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation, J. Immunol. 2006 Jun;176(12):7288-300.